Pure Global

Nasogastric/Orogastric Tube Placement Confirmation in Neonates Utilizing Self-contained pH Device, a Feasibility Study - Trial NCT06274944

Access comprehensive clinical trial information for NCT06274944 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Minnesota and is currently Recruiting. The study focuses on Premature Birth. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06274944
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT06274944
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Nasogastric/Orogastric Tube Placement Confirmation in Neonates Utilizing Self-contained pH Device, a Feasibility Study

Study Focus

Premature Birth

nasogastric tube placement pH confirmation device

Observational

device

Sponsor & Location

University of Minnesota

Minneapolis, United States of America

Timeline & Enrollment

N/A

Feb 12, 2024

Jan 31, 2025

30 participants

Primary Outcome

PH reading comparison

Summary

This study is looking at using a self-contained pH device that will assist in confirming
 placement of a nasogastric or orogastric tube placed in the stomach of hospitalized infants.

ICD-10 Classifications

Fetus and newborn affected by precipitate delivery
Preterm delivery without spontaneous labour
Disorders related to short gestation and low birth weight, not elsewhere classified
Other preterm infants
Preterm spontaneous labour with preterm delivery

Data Source

ClinicalTrials.gov

NCT06274944

Device Trial